Volume 62, Issue 1, January 2013

ISSN: 0340-7004 (Print) 1432-0851 (Online)

In this issue (19 articles)

  1. Editorial

    Looking to the future of cancer immunotherapy: many questions to answer and many therapeutic opportunities

    Suzanne Ostrand-Rosenberg Pages 1-2
    Download PDF (89KB) View Article

  2. No Access

    Original article

    High lipid content of irradiated human melanoma cells does not affect cytokine-matured dendritic cell function

    Gabriela A. Pizzurro, Florencia P. Madorsky Rowdo… Pages 3-15
    Look Inside Get Access

  3. No Access

    Original article

    FDG PET scans as evaluation of clinical response to dendritic cell vaccination in patients with malignant melanoma

    Lotte Engell-Noerregaard, Helle W. Hendel… Pages 17-25
    Look Inside Get Access

  4. No Access

    Original Article

    T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer

    Kathrin Bauer, Nina Nelius, Miriam Reuschenbach… Pages 27-37
    Look Inside Get Access

  5. No Access

    Original article

    Lenalidomide enhances anti-myeloma cellular immunity

    Katarina Luptakova, Jacalyn Rosenblatt… Pages 39-49
    Look Inside Get Access

  6. No Access

    Original Article

    T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile

    Shahryar Kiaii, Parviz Kokhaei, Fariba Mozaffari… Pages 51-63
    Look Inside Get Access

  7. No Access

    Original article

    Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients

    Lili Yang, Baozhu Ren, Hui Li, Jinpu Yu, Shui Cao… Pages 65-73
    Look Inside Get Access

  8. No Access

    Original article

    Generation and immunologic functions of Th17 cells in malignant gliomas

    Manjeera Paladugu, Archana Thakur, Lawrence G. Lum… Pages 75-86
    Look Inside Get Access

  9. No Access

    Original Article

    B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion

    Yu Zhang, Yair Eliav, Seung-uon Shin… Pages 87-99
    Look Inside Get Access

  10. No Access

    Original article

    Distinct in vivo CD8 and CD4 T cell responses against normal and malignant tissues

    David Coe, Caroline Addey, Matthew White, Nida Harwood… Pages 101-112
    Look Inside Get Access

  11. No Access

    Original article

    CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients

    Mercedes Borge, Paula Romina Nannini… Pages 113-124
    Look Inside Get Access

  12. Original article

    Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma

    Surasak Phuphanich, Christopher J. Wheeler… Pages 125-135
    Download PDF (601KB) View Article

  13. Original article

    Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer

    Nadeem A. Sheikh, Daniel Petrylak, Philip W. Kantoff… Pages 137-147
    Download PDF (561KB) View Article

  14. No Access

    Original Article

    Memory T cells are uniquely resistant to melanoma-induced suppression

    Lucy Wentworth, Justin V. Meyers, Sheeba Alam… Pages 149-159
    Look Inside Get Access

  15. No Access

    Original article

    Increased prevalence of tumor-infiltrating regulatory T cells is closely related to their lower sensitivity to H2O2-induced apoptosis in gastric and esophageal cancer

    Shinichirou Izawa, Kousaku Mimura, Mitsuaki Watanabe… Pages 161-170
    Look Inside Get Access

  16. No Access

    Original Article

    Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine

    Shiwen Peng, Sofia Lyford-Pike, Belinda Akpeng… Pages 171-182
    Look Inside Get Access

  17. No Access

    Original article

    A knockdown of Maml1 that results in melanoma cell senescence promotes an innate and adaptive immune response

    Shijun Kang, Jianmin Xie, Jingxia Miao, Rong Li… Pages 183-190
    Look Inside Get Access

  18. No Access

    Short communication

    MAGE-C1/CT7 and MAGE-C2/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy

    Fabricio de Carvalho, Veruska L. F. Alves… Pages 191-195
    Look Inside Get Access

  19. No Access

    Meeting report

    “Tumor Immunology Meets Oncology (TIMO) VIII” from May 4 to 5, 2012, in Halle/Saale, Germany

    Diana Barthel, Barbara Seliger Pages 197-202
    Look Inside Get Access